Neuberger Small-Mid Cap ETF NBSM
Set alert
As of Oct 30, 3:59 PM ET
- YTD
- +13.83%
- 1 year
- +14.97%
- Open
- 28.94
- Prev close
- 28.98
- Mkt cap
- 228.34M
- Vol
- 14.96K
- Avg vol
- 14.07K
- EPS
- 1.36
- P/E
- 21.16
- Div yield
- 0.00%
More statistics
- Low
- 28.62
- High
- 29.05
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 26.91
- 200-d avg
- 25.82
News
3 weeks ago benzinga.com
Haemonetics Stock Hits 52-Week High - Here's Why
Haemonetics stock hits a new 52-week high after CSL Plasma outlines a sweeping rollout of its technology across existing U.S. centers.
1 year ago benzinga.com
Toro Lowers Full-Year Outlook As Residential Sales Slump, Costs Weigh on Margins
Toro Q2 sales down 2% Y/Y to $1.32B, missing consensus of $1.35B. Residential segment sales fell 11.4%, segment earnings down to $16.1M from $36.1M. Professional segment sales up 0.8%, segment…
1 year ago benzinga.com
ITT Q1 Preliminary Results: Flat Revenue, Eyes $1 Billion In Orders, $500 Million In New Buybacks & More
ITT shares down premarket as company reports preliminary Q1 results and announces intent to repurchase up to $500 million in shares
1 year ago benzinga.com
Toro's Q1 Sales Miss Expectations, Weighed Down by Material Costs and Promotions
Toro Co (NYSE: TTC) reported lower Q1 fiscal 2025 results, with sales down 1% Y/Y to $995M. Adjusted EPS of $0.65 beat consensus of $0.63. FY25 outlook reaffirmed.
-
1 year ago benzinga.com
'Russian Nesting Doll' Of Problems: MSTX And DIPS Top Morningstar's Worst ETF List For 2024
Two leveraged exchange-traded funds (ETFs) have been identified as the worst performers of the year, according to Morningstar.
-
2 years ago benzinga.com
Why Is Outdoor Equipment Products Provider Toro Stock Plunging Today?
Toro Co shares down after reporting Q3 results with sales increase of 6.9% but missing consensus, adjusted gross margin and operating margin up, adjusted EPS misses and lower FY24 outlook due to…
-
2 years ago benzinga.com
Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst
Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix analysis. Price target set at $112.
-
2 years ago benzinga.com
Why Is RBC Bearings Stock Trading Higher Today?
RBC Bearings reported Q4 results with net sales up 4.9%, gross margin and EBITDA margin expanding. Backlog at $726.1M. Adjusted EPS beat estimates.